Advances in applications of siRNA in cancer therapy: challenges and opportunities
Clinical and Translational Oncology · 18.07.2026
DOI: 10.1007/s12094-026-04497-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 18.07.2026. Verfasst von Mohamad Mehrparvar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Daneshghah Ave, Tabriz, Iran. Die Arbeit nennt 104 Literaturangaben.
Abstract (Originalsprache)
This review comprehensively examines recent advances in the application of small interfering RNA (siRNA) in cancer therapy. The introductory section highlights the complex mechanisms of siRNA and its critical role in gene regulation and silencing, which are essential for inhibiting cancer progression. A detailed discussion explores combination therapy approaches, focusing on how siRNA can be integrated with conventional and emerging therapeutic modalities to achieve synergistic effects. Particular emphasis is placed on the potential of these combination strategies to enhance therapeutic efficacy and improve treatment outcomes. The review also summarizes key clinical trials that provide valuable insights into the progress of siRNA-based therapeutics. Despite these advances, the clinical application of siRNA in cancer therapy continues to face significant challenges, particularly with respect to delivery systems and off-target effects. Through a critical evaluation of these opportunities and limitations, this review highlights the potential of siRNA as a promising therapeutic tool in oncology while emphasizing the need for further research to optimize its clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology Research Center, Tabriz University of Medical Sciences, Daneshghah Ave, Tabriz, Iran.
- Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL, USA.
- Department of Genetics, College of Medicine, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, USA.
- Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Immunology Research Center, Tabriz University of Medical Sciences, Daneshghah Ave, Tabriz, Iran. akbarimo@tbzmed.ac.ir.
Zitieren
APA
Mehrparvar, M., Shabani, S., Oruji, F., Hajazimian, S., Nasiri, H., Khansalar, S., Behroozi, J., Isazadeh, A., & Akbari, M. (2026). Advances in applications of siRNA in cancer therapy: challenges and opportunities. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04497-0
Vancouver
Mehrparvar M, Shabani S, Oruji F, Hajazimian S, Nasiri H, Khansalar S, et al. Advances in applications of siRNA in cancer therapy: challenges and opportunities. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04497-0
BibTeX
@article{Mehrparvar2026,
author = {Mehrparvar, Mohamad and Shabani, Shima and Oruji, Farshid and Hajazimian, Saba and Nasiri, Hadi and Khansalar, Soolmaz and Behroozi, Javad and Isazadeh, Alireza and Akbari, Morteza},
title = {Advances in applications of siRNA in cancer therapy: challenges and opportunities},
journal = {Clinical and Translational Oncology},
year = {2026},
doi = {10.1007/s12094-026-04497-0}
}
EUVIMED